OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FDX1 inhibits thyroid cancer malignant progression by inducing cuprotosis
Gaoxiang Chen, Jianan Zhang, Weifeng Teng, et al.
Heliyon (2023) Vol. 9, Iss. 8, pp. e18655-e18655
Open Access | Times Cited: 15

Showing 15 citing articles:

Biomimetic copper-doped polypyrrole nanoparticles induce glutamine metabolism inhibition to enhance breast cancer cuproptosis and immunotherapy
Ni Zhang, Ping Wei, Kexiang Rao, et al.
Journal of Controlled Release (2024) Vol. 371, pp. 204-215
Closed Access | Times Cited: 16

Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases
Juanjuan Han, Jiayi Luo, C Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116570-116570
Open Access | Times Cited: 8

Protein lipoylation: mitochondria, cuproptosis, and beyond
Cheng-Han Lin, Yeh Chin, Ming Zhou, et al.
Trends in Biochemical Sciences (2024) Vol. 49, Iss. 8, pp. 729-744
Closed Access | Times Cited: 8

Cuproptosis-Related Gene FDX1 Suppresses the Growth and Progression of Colorectal Cancer by Retarding EMT Progress
Chao Wang, Jingjing Guo, Yun Zhang, et al.
Biochemical Genetics (2024)
Open Access | Times Cited: 5

Effects of Trace Elements on Endocrine Function and Pathogenesis of Thyroid Diseases—A Literature Review
Łukasz Bryliński, Katarzyna Kostelecka, Filip Woliński, et al.
Nutrients (2025) Vol. 17, Iss. 3, pp. 398-398
Open Access

Novel immune cross-talk between inflammatory bowel disease and IgA nephropathy
Qianqian Yan, Zihao Zhao, Dongwei Liu, et al.
Renal Failure (2024) Vol. 46, Iss. 1
Open Access | Times Cited: 4

The Role of Cuproptosis Key Factor FDX1 in Gastric Cancer
Qiqi Zhao, Miao Yu, Xueqin Du, et al.
Current Pharmaceutical Biotechnology (2024) Vol. 26, Iss. 1, pp. 132-142
Closed Access | Times Cited: 3

Quercetin Attenuates Acute Kidney Injury Caused by Cisplatin by Inhibiting Ferroptosis and Cuproptosis
Mengqi Shi, Youchaou Mobet, Hong C. Shen
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 2687-2699
Closed Access | Times Cited: 2

METTL3 promotes Non-Small-Cell Lung Cancer Growth and Metastasis by Inhibiting FDX1 Through Copper Death-Associated Pri-miR-21-5p Maturation
Shuai Qian, Jun Liu, Wenliang Liao, et al.
Epigenomics (2023) Vol. 15, Iss. 23, pp. 1237-1255
Closed Access | Times Cited: 7

Exploring Copper’s role in stroke: progress and treatment approaches
Gang‐Ding Peng, Yongpan Huang, Guangdi Xie, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1

Cuproptosis associated cytoskeletal destruction contributes to podocyte injury in chronic kidney disease
Han Li, Yingjie Fu, Yue Xu, et al.
AJP Cell Physiology (2024) Vol. 327, Iss. 2, pp. C254-C269
Closed Access

Cuproptosis: A New Approach to Treating Tumors
志腾 安
Advances in Clinical Medicine (2024) Vol. 14, Iss. 10, pp. 161-167
Closed Access

Down-regulated FDX1 inhibited the proliferation and migration of renal cell carcinoma cells
Zhijie Bai, Chunhui Wang, Mingpeng Zhang, et al.
Research Square (Research Square) (2023)
Open Access

Page 1

Scroll to top